GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Invitro International (OTCPK:IVRO) » Definitions » Total Liabilities

Invitro International (Invitro International) Total Liabilities : $0.19 Mil (As of Jun. 2097)


View and export this data going back to 1991. Start your Free Trial

What is Invitro International Total Liabilities?

Invitro International's Total Liabilities for the quarter that ended in Jun. 2097 was $0.19 Mil.

Invitro International's quarterly Total Liabilities increased from Dec. 2096 ($0.00 Mil) to Mar. 2097 ($0.26 Mil) but then declined from Mar. 2097 ($0.26 Mil) to Jun. 2097 ($0.19 Mil).

Invitro International's annual Total Liabilities declined from Sep. 2094 ($0.90 Mil) to Sep. 2095 ($0.40 Mil) and declined from Sep. 2095 ($0.40 Mil) to Sep. 2096 ($0.30 Mil).


Invitro International Total Liabilities Historical Data

The historical data trend for Invitro International's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Invitro International Total Liabilities Chart

Invitro International Annual Data
Trend Feb90 Feb91 Sep92 Sep93 Sep94 Sep95 Sep96
Total Liabilities
Get a 7-Day Free Trial 1.10 0.80 0.90 0.40 0.30

Invitro International Quarterly Data
Sep92 Dec92 Mar93 Jun93 Sep93 Dec93 Mar94 Jun94 Sep94 Dec94 Mar95 Jun95 Sep95 Dec95 Mar96 Jun96 Sep96 Dec96 Mar97 Jun97
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.30 0.30 - 0.26 0.19

Invitro International Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Invitro International's Total Liabilities for the fiscal year that ended in Sep. 2096 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=0.4+(0+-0.1
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+0)
=0.30

Total Liabilities=Total Assets (A: Sep. 2096 )-Total Equity (A: Sep. 2096 )
=2.4-2.1
=0.30

Invitro International's Total Liabilities for the quarter that ended in Jun. 2097 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=0.193+(0+0
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+0)
=0.19

Total Liabilities=Total Assets (Q: Jun. 2097 )-Total Equity (Q: Jun. 2097 )
=1.151-0.958
=0.19

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Invitro International Total Liabilities Related Terms

Thank you for viewing the detailed overview of Invitro International's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Invitro International (Invitro International) Business Description

Traded in Other Exchanges
N/A
Address
330 East Orangethorpe Avenue, Suite D, Placentia, CA, USA, 92870
Invitro International is a provider of non-animal testing methods. The company develops and commercializes test kits and laboratory services. Its testing technologies are designed to produce data regarding corrosivity, or ocular/dermal irritation, which correlate with animal and human test results. Its products and services include Irritection, Corrositex, and Lab Services. The company provides its products to various industries such as cosmetics, personal care, household products, textiles, pharmaceuticals, chemicals, and hazardous waste transportation. The majority of its revenue is generated from the United States and it also exports to other countries.